Metabolic Acidosis in Chronic Kidney Disease
Also known as: Metabolic Acidosis of Chronic Kidney Disease
Metabolic acidosis in chronic kidney disease is a serum bicarbonate under 22 mmol/L due to reduced renal net acid excretion. Prevalence rises from 5% at stage G3a to more than 30% at G4 to G5. The daily endogenous and dietary acid load is about 1 mmol/kg; the failing kidney cannot generate enough ammonia and excrete titratable acid, so buffers (bone, muscle) are consumed. Early disease produces a normal anion gap (hyperchloraemic) acidosis; advanced disease adds a raised anion gap from retained phosphate, sulphate and organic anions.
Consequences. Faster decline in eGFR, bone demineralisation and fracture, muscle protein catabolism and sarcopenia, insulin resistance, hyperkalaemia, impaired growth in children, worse cardiovascular outcomes, and higher mortality.













